Martin F Fromm

40PUBLICATIONS
96CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Biomolecular modelling and designGene and molecular therapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 24, 2026
Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage.

|Jul 16, 2026
Development and analysis of a SmPC-based machine-readable dataset of contraindications for clinical decision support and real-world data analysis.

|Jul 04, 2026
Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers.

|Jun 03, 2026
Deorphanisation and functional characterisation of OATP5A1 as transport protein for amino acids and vitamins.

|May 19, 2026
Therapeutic Drug Monitoring of Imatinib in Paediatric Chronic Myeloid Leukaemia: Towards Practical Implementation and Interpretation of Measured Plasma Concentrations.

|Dec 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data.

Michael I Sponfeldner, Pauline Dürr, Phyllis Lensker

Pageof 7

Frequent Collaborators

14 joint publications

Jörg König

11 joint publications

Arne Gessner

10 joint publications

Renke Maas

10 joint publications

Pauline Dürr